Researchers in San Diego and North Carolina have been awarded up to $186 million in federal funds for financing the development of an AIDS vaccine.
The financing grant will go to the Scripps Research Institute in La Jolla and North Carolina’s Duke University.
Scripps will receive about $77 million over the seven-year life of the financing grant.
It was awarded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
For further deal information visit Current Agreements (subscription required)
Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary
Report: AIDS Partnering 2007-2013
View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value
View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making
View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity
View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity